COMMUNIQUÉS West-GlobeNewswire

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program

19/06/2018 - 15:00

Leading Cannabinoid Biotechnology Company Receives Patent Allowance on Invention of Method to Extract and Purify the Most Commonly Known Cannabinoid Molecule from Medicinal Cannabis NEW YORK, June 19, 2018 (GLOBE [...]

City View Green: A Promising New ACMPR Applicant About to Go Public -- CFN Media

19/06/2018 - 14:50

SEATTLE, WA , June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

48North Cannabis: A Vertically-Integrated Brand Portfolio Focused on Women -- CFN Media

19/06/2018 - 14:45

SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

Cannabis Industry Pioneers Blockchain Adoption -- CFN Media

19/06/2018 - 14:45

SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.

19/06/2018 - 14:45

Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter of intent (“LOI”) [...]

Marrone Bio Innovations Co-Sponsors “The Grow Off” in Colorado

19/06/2018 - 14:31

Cannabis Growing Competition to Judge Colorado-based Growers on the Terpene Content, Yield and Potency of Plant DAVIS, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a [...]

Apellis Pharmaceuticals to Host R&D Day on June 26, 2018

19/06/2018 - 14:30

CRESTWOOD, Ky. and CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation

19/06/2018 - 14:30

Data demonstrate CNDO-109-activated NK cells are safe, well tolerated and capable of extending complete remissions in high-risk acute myeloid leukemia patients NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- Fortress [...]

Avenue Therapeutics to Participate in JMP Securities Life Sciences Conference

19/06/2018 - 14:30

NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq:ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today [...]

Psoria-Shield, Inc. Expands Relationship with Prominent Healthcare Organization

19/06/2018 - 14:30

HOFFMAN ESTATES, IL, June 19, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI), today announced that its wholly‐owned subsidiary, Psoria-Shield, Inc. (PSI), has sold and delivered another Psoria-Light® [...]

Agritek Holdings, Inc. Announces Grand Opening Of Wellness And Vacation Resort Property In Quebec, Canada As New Recreational Regulations For Country Are Approved

19/06/2018 - 14:30

LOS ANGELES, CA, June 19, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Saratoga Region Votes Dr. Yarinsky as Best Plastic Surgeon for Sixth Year

19/06/2018 - 14:05

Saratoga Today, a newspaper local to the Saratoga, New York area, has recognized Dr. Steven Yarinsky and his plastic surgery practice as the region’s “Best of 2018.” SARATOGA SPRINGS, N.Y., June 19, 2018 (GLOBE NEWSWIRE [...]

Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction

19/06/2018 - 14:00

PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon dilation with ongoing [...]

IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™

19/06/2018 - 14:00

SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a “Notice of Intention [...]

CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018

19/06/2018 - 14:00

NEWARK, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet [...]

Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation

19/06/2018 - 14:00

WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United States Patent No. 9, [...]

Allena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease

19/06/2018 - 14:00

-- ALLN-346, a Novel, Engineered, Urate Oxidase, Demonstrates Robust Reduction of Plasma and Urine Uric Acid After Oral Administration in an Animal Model of Hyperuricemia -- -- Data Supports Advancement of ALLN-346 as [...]

Catalyst Biosciences to Present at the JMP Securities 2018 Life Sciences Conference

19/06/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]

7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance

19/06/2018 - 14:00

Stealth start-up company debuts with support from NIH and Leading Immuno-Oncology Experts HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel [...]